NYSE:BIO.B - Bio-Rad Laboratories Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $302.00 0.00 (0.00 %) (As of 05/21/2019 04:00 PM ET)Previous Close$302.00Today's Range$302.00 - $302.0052-Week Range$220.93 - $324.25Volume1 shsAverage Volume177 shsMarket Capitalization$9.00 billionP/E Ratio47.71Dividend YieldN/ABeta1.11 ProfileChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the Pacific Rim, the United States, and internationally. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Receive BIO.B News and Ratings via Email Sign-up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Analytical instruments Sub-IndustryN/A SectorMedical Current SymbolNYSE:BIO.B Previous Symbol CUSIPN/A CIK12208 Webhttp://www.bio-rad.com/ Phone510-724-7000Debt Debt-to-Equity Ratio0.13 Current Ratio4.57 Quick Ratio3.24Price-To-Earnings Trailing P/E Ratio47.71 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.29 billion Price / Sales3.93 Cash Flow$5.9285 per share Price / Cash Flow50.94 Book Value$163.22 per share Price / Book1.85Profitability EPS (Most Recent Fiscal Year)N/A Net Income$365.61 million Net Margins24.84% Return on Equity4.15% Return on Assets2.99%Miscellaneous Employees8,000 Outstanding Shares29,799,000Market Cap$9.00 billion Next Earnings Date8/6/2019 (Estimated) OptionableNot Optionable Bio-Rad Laboratories (NYSE:BIO.B) Frequently Asked Questions What is Bio-Rad Laboratories' stock symbol? Bio-Rad Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "BIO.B." How were Bio-Rad Laboratories' earnings last quarter? Bio-Rad Laboratories, Inc. (NYSE:BIO.B) issued its quarterly earnings data on Thursday, February, 28th. The company reported $2.13 earnings per share for the quarter. The company earned $617.54 million during the quarter. Bio-Rad Laboratories had a return on equity of 4.15% and a net margin of 24.84%. View Bio-Rad Laboratories' Earnings History. When is Bio-Rad Laboratories' next earnings date? Bio-Rad Laboratories is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Bio-Rad Laboratories. Has Bio-Rad Laboratories been receiving favorable news coverage? Media headlines about BIO.B stock have been trending somewhat positive this week, according to InfoTrie. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Bio-Rad Laboratories earned a news impact score of 1.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near term. Who are some of Bio-Rad Laboratories' key competitors? Some companies that are related to Bio-Rad Laboratories include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Fluidigm (FLDM), Quanterix (QTRX), Eyepoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO) and HTG Molecular Diagnostics (HTGM). What other stocks do shareholders of Bio-Rad Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bio-Rad Laboratories investors own include Accelerate Diagnostics (AXDX), Calithera Biosciences (CALA), Aptose Biosciences (APTO), Gamma Communications (GAMA), United Rentals (URI), Newell Brands (NWL), Deluxe (DLX), NVIDIA (NVDA), Netflix (NFLX) and New Gold (NGD). Who are Bio-Rad Laboratories' key executives? Bio-Rad Laboratories' management team includes the folowing people: Mr. Norman D. Schwartz, Chairman, CEO & Pres (Age 69)Ms. Christine A. Tsingos, Exec. VP & CFO (Age 60)Mr. John Goetz, Consultant (Age 69)Mr. John Hertia, Exec. VP & Pres of Clinical Diagnostics Group (Age 63)Mr. Michael Crowley, Exec. VP of Global Commercial Operations (Age 57) How do I buy shares of Bio-Rad Laboratories? Shares of BIO.B can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Bio-Rad Laboratories' stock price today? One share of BIO.B stock can currently be purchased for approximately $302.00. How big of a company is Bio-Rad Laboratories? Bio-Rad Laboratories has a market capitalization of $9.00 billion and generates $2.29 billion in revenue each year. Bio-Rad Laboratories employs 8,000 workers across the globe. What is Bio-Rad Laboratories' official website? The official website for Bio-Rad Laboratories is http://www.bio-rad.com/. How can I contact Bio-Rad Laboratories? Bio-Rad Laboratories' mailing address is 1000 ALFRED NOBEL DR, HERCULES CA, . The company can be reached via phone at 510-724-7000 or via email at [email protected] MarketBeat Community Rating for Bio-Rad Laboratories (NYSE BIO.B)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 98 (Vote Outperform)Underperform Votes: 144 (Vote Underperform)Total Votes: 242MarketBeat's community ratings are surveys of what our community members think about Bio-Rad Laboratories and other stocks. Vote "Outperform" if you believe BIO.B will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BIO.B will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/21/2019 by MarketBeat.com StaffFeatured Article: Limitations of the P/E Growth ratio Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.